InsidersTradesSigma
Moberg Pharma AB (publ) Stock: price and insider trades · Finland · FIN-FSA
Track the Moberg Pharma AB (publ) share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Moberg Pharma AB (publ) has recorded 5 insider filings. Market capitalisation: €441.6m. The latest transaction was filed on 7 July 2026 (Purchase). Among the most active insiders: Richard Ding. The full history is accessible without an account.
5
Insider Decl.
0
Thresholds
€22,142
5 ops.
Buy Volume
·
0 ops.
Sell Volume
34Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 July 2026
Declarations5 total
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
11,816 shares@ SEK 9.340.025% mcap100.0% of flowAktieFI:csv-93e3785d79c2837151df
Ideal exit: 3 Apr 2027 (T+270)
11,201 shares@ SEK 9.340.023% mcap100.0% of flowAktieFI:csv-f021a2ee92c1b1e52232
Ideal exit: 3 Apr 2027 (T+270)
1,000 shares@ €0.74630.0001% mcap26.8% of flowAktieFI:A003U081-1
Ideal exit: 18 Aug 2026 (T+270)
1,600 shares@ €0.76370.0002% mcap43.8% of flowAktieFI:A003U065-1
Ideal exit: 16 Aug 2026 (T+270)
1,000 shares@ €0.82150.0002% mcap29.4% of flowAktieFI:A003T733-1
Ideal exit: 11 Aug 2026 (T+270)
5 of 5 declarations
About Moberg Pharma AB (publ)
Moberg Pharma AB (publ) is a Swedish pharmaceutical company focused on developing treatments for skin diseases. It is listed on the Stockholm Stock Exchange (XSTO).